ProShares Ultra Health Care
20 hedge funds and large institutions have $7.3M invested in ProShares Ultra Health Care in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
12% more capital invested
Capital invested by funds: $6.54M → $7.3M (+$757K)
5% more funds holding
Funds holding: 19 → 20 (+1)
1.27% more ownership
Funds ownership: 16.45% → 17.72% (+1.3%)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $356K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Neuberger Berman Group
New York
|
+$1.17M |
| 2 |
IMC Chicago
Chicago,
Illinois
|
+$901K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$152K |
| 4 |
OP
ORG Partners
Roanoke,
Indiana
|
+$83.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$20.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$703K |
| 2 |
First Manhattan
New York
|
-$602K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$575K |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
-$207K |
| 5 |
PFA
Plotkin Financial Advisors
Chevy Chase,
Maryland
|
-$80.4K |
RXL Hedge Fund Activity: Q4 2023 in Review
20 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra Health Care (RXL) for Q4 2023, worth a combined $7.3M — up 12% from $6.54M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new RXL positions and 4 closed out — a net gain of 1 holder — while 3 added to existing stakes and 5 trimmed.
The largest buyer was Neuberger Berman Group, opening a new position worth an estimated $1.17M. The largest seller was Citadel Advisors, exiting entirely with an estimated $703K sold.
- 20 institutional investors held ProShares Ultra Health Care (RXL) as of Q4 2023, up from 19 in Q3 2023.
- Funds reported $7.3M of ProShares Ultra Health Care stock for Q4 2023, up 12% quarter-over-quarter.
- 5 funds opened new ProShares Ultra Health Care positions in Q4 2023 and 4 closed out, a net change of +1 holder.
- The largest ProShares Ultra Health Care buyer in Q4 2023 was Neuberger Berman Group, an estimated $1.17M added.
- The largest ProShares Ultra Health Care seller in Q4 2023 was Citadel Advisors, an estimated $703K sold.
Based on aggregated 13F filings for Q4 2023.